3rd Quarter - Amendment
CURE SMA for CURE SMA
Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 21, 2019 | $60,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 30, 2020 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
biomedical research funding, newborn screening appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYNARD FRIESZ New | Leg. Asst & Dir. Special Projects, Sen. Byron Dorgan, Jan. 1998 to May 2010 |
Health Issues HCR
newborn screening, biomedical research funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYNARD FRIESZ New | Leg. Asst & Dir. Special Projects, Sen. Byron Dorgan, Jan. 1998 to May 2010 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.